Viewing Study NCT03541902


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2025-12-26 @ 3:00 AM
Study NCT ID: NCT03541902
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-09
First Post: 2018-05-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module